LISA DE BENEDET: Open Payments
NPI 1750706628 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 16 payments from 7 companies in 2025. Trend: 2023 $250 · 2024 $291 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 4 | $64 |
| Boston Scientific Corporation | 2 | $57 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| Abbott Laboratories | 2 | $41 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: LEQVIO, CAMZYOS, LUX-Dx Insertable Cardiac Monitor, VERQUVO, CARDIOMEMS, EDARBI, REPATHA.
Industry payments across TX — which companies pay providers there.
